NexImmune, a start-up company formed in part by US-based Johns Hopkins University School of Medicine faculty members, has hired both a executive president and a chairman of its clinical and scientific advisory board as part of a technology transfer license for developing immunity against diseases and cancers. Kenneth Carter has joined NexImmune as its executive…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
